Agilent Technologies, Inc. (A)
| Market Cap | 42.35B |
| Revenue (ttm) | 6.95B |
| Net Income (ttm) | 1.30B |
| Shares Out | 283.05M |
| EPS (ttm) | 4.57 |
| PE Ratio | 32.77 |
| Forward PE | 25.18 |
| Dividend | $1.02 (0.68%) |
| Ex-Dividend Date | Jan 6, 2026 |
| Volume | 937,306 |
| Open | 150.96 |
| Previous Close | 150.10 |
| Day's Range | 149.22 - 151.46 |
| 52-Week Range | 96.43 - 160.27 |
| Beta | 1.27 |
| Analysts | Buy |
| Price Target | 162.29 (+8.47%) |
| Earnings Date | Nov 24, 2025 |
About A
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry inst... [Read more]
Financial Performance
In 2025, Agilent Technologies's revenue was $6.95 billion, an increase of 6.73% compared to the previous year's $6.51 billion. Earnings were $1.30 billion, an increase of 1.09%.
Financial StatementsAnalyst Summary
According to 14 analysts, the average rating for A stock is "Buy." The 12-month stock price target is $162.29, which is an increase of 8.47% from the latest price.
News
Agilent Announces 21 CFR Part 11 Compliance Software for xCELLigence RTCA eSight
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc (NYSE: A) today announced the release of a new 21 CFR Part 11 compliance software for the Agilent xCELLigence Real-Time Cell Analysis (RT...
Agilent Technologies: Steady As She Goes
Agilent Technologies delivered strong Q4 2025 results, with revenue and EPS beating expectations and robust growth in Life Sciences and Diagnostics segment. Management forecasts FY26 revenue growth of...
Top small-cap plays for 2026
The Investment Committee debates their top small- and mid-cap names for 2026.
These Analysts Boost Their Forecasts On Agilent After Upbeat Q4 Results
Agilent Technologies Inc (NYSE: A) reported upbeat earnings for the fourth quarter on Monday.
Agilent Technologies, Inc. (A) Q4 2025 Earnings Call Transcript
Agilent Technologies, Inc. ( A) Q4 2025 Earnings Call November 24, 2025 4:30 PM EST Company Participants Tejas Savant Padraig McDonnell - CEO, President & Director Adam Elinoff - Senior VP, CFO & Pri...
Agilent Technologies, Inc. (A) Presents at Bank of America Global Healthcare Conference 2025 Transcript
Agilent Technologies, Inc. ( A) Bank of America Global Healthcare Conference 2025 September 25, 2025 4:50 AM EDT Company Participants Padraig McDonnell - CEO, President & Director Conference Call Par...
Agilent Reports Fourth-Quarter Fiscal Year 2025 Financial Results
SANTA CLARA, Calif.--(BUSINESS WIRE)---- $A #BringGreatScienceToLife--Agilent Technologies, Inc. (NYSE: A) today reported revenue of $1.86 billion for the fourth quarter ended October 31, 2025, exceed...
Agilent beats quarterly revenue estimates on strong demand for lab tools
Life sciences firm Agilent Technologies on Monday beat fourth-quarter revenue estimates, helped by strong demand for medical tools and equipment used in lab research and diagnostic services.
Josh Brown's ‘best stocks in the market': Health Care
Josh Brown, CEO of Ritholtz Wealth Management, joins CNBC's 'Halftime Report' to explain why he's spotlighting Health Care in his "best stocks in the market." The Committee debates their health care s...
Top Wall Street Forecasters Revamp Agilent Expectations Ahead Of Q4 Earnings
Agilent Technologies, Inc. (NYSE: A) will release earnings results for the fourth quarter, after the closing bell on Monday, Nov. 24.
Agilent Announces Cash Dividend of 25.5 Cents Per Share
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced a quarterly dividend of 25.5 cents per share of common stock. The quarterly dividend will be paid on Jan. 28, ...
Agilent to Participate in Citi's 2025 Global Healthcare Conference
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced that Chief Enterprise Transformation Officer Tom Callihan and Head of Investor Relations Tejas Savant will par...
Agilent Research Catalyst (ARC) Award Presented to UC Davis for Breakthroughs in Peptide Therapeutics
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced that the University of California has received an Agilent Research Catalyst (ARC) award on behalf of Professor...
Agilent to Announce Fourth-Quarter Fiscal Year 2025 Financial Results on Nov. 24
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) will release financial results for the fourth quarter of fiscal year 2025 after the stock market closes on Monday, Nov. 24. Th...
Agilent Names Adam S. Elinoff as Chief Financial Officer
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the appointment of Adam S. Elinoff as chief financial officer, effective Nov. 17. Elinoff brings two decades o...
Agilent Announces New Insight Series Alarm Resolution Systems for Airport Security Screening
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the launch of its new Insight Series Alarm Resolution Systems, designed to enhance safety and streamline opera...
Agilent Introduces the Altura Line of Inert HPLC Columns for Superior Results in Biotherapeutic Testing
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the release of a new range of high performance liquid chromatography (HPLC) columns ideally suited for biother...
Agilent Technologies, Inc. (A) gilent Technologies, Inc. Presents at Bank of merica Global Healthcare Conference 2025 Transcript
Agilent Technologies, Inc. (NYSE:A) gilent Technologies, Inc. Bank of merica Global Healthcare Conference 2025 September 25, 2025 4:50 AM EDT Company Participants Padraig McDonnell - CEO, President &...
Lunit and Agilent Technologies Announce Collaboration to Enhance Development of Companion Diagnostic Solutions Powered with AI for Precision Medicine
Collaboration combines Lunit's AI expertise with Agilent's diagnostic leadership to revolutionize biomarker testing and enhance precision medicine capabilities SEOUL, South Korea , Sept. 22, 2025 /PRN...
Agilent Announces Cash Dividend of 24.8 Cents per Share
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies, Inc. (NYSE: A) today announced a quarterly dividend of 24.8 cents per share of common stock. The quarterly dividend will be paid on Oct. 22,...
Agilent to Participate in 2025 Bank of America Global Healthcare Conference
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced that President and CEO Padraig McDonnell will participate in a fireside chat at this year's Bank of America Gl...
Agilent Refurbishment Centers Achieve Top-Level My Green Lab Certification
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced that its Refurbishment Centers in Delaware, USA, and Singapore have achieved the highest level of My Green Lab...
Agilent (A) CEO on PFAS Testing Growth & Creating Advanced Instruments for Science
Padraig McDonnell, CEO of Agilent (A), joins to discuss the company's latest earnings. Agilent creates analytical instruments and software for life science markets: “we enable breakthroughs” in areas ...
Agilent Technologies, Inc. (A) Presents At Wells Fargo 20th Annual Healthcare Conference 2025 Transcript
Agilent Technologies, Inc. (NYSE:A) Wells Fargo 20th Annual Healthcare Conference 2025 September 3, 2025 11:00 AM EDT Company Participants Padraig McDonnell - CEO, President & Director Rodney Gonsalv...
Agilent to Showcase New Dako Omnis Family at European Congress of Pathology 2025
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced its participation as a premium sponsor at the upcoming European Congress of Pathology (ECP) 2025, taking place...